Orbis Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Orbis Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11197
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Orbis Biosciences Inc (Orbis) is a developer of pharmaceutical products that offers optimizes oral and injectable products. The company provides preclnical pipeline indications for pathologies including cancer, bronchiolitis, Eczema, atopic dermatitis, nephrotic syndrome, HIV, asthma, buninectomy, head and neck cancers, steroid responsive inner ear conditions, chest congestion, hemorrphoidectomy; and for post-surgical pain management, contraceptives, and animal health. It develops novel controlled-release delivery system. Orbis creates oral and injectable therapeutics to improve compliance and patient satisfaction. The company products address clinical needs and are at various stages of development. The company caters pharmaceuticals, consumer products, foods and beverages and chemical industries. Orbis is headquartered in Lenexa, Kansas, the US.

Orbis Biosciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Orbis Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Orbis Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Dare Bioscience Enters into Development and Option Agreement with Orbis Biosciences 11
FHI 360 Enters into Co-Development Agreement with Orbis Biosciences 12
Debt Offering 13
Orbis Biosciences Raises USD0.99 Million in Debt Offering 13
Orbis Biosciences Inc – Key Competitors 14
Orbis Biosciences Inc – Key Employees 15
Orbis Biosciences Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Orbis Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Orbis Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Orbis Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Dare Bioscience Enters into Development and Option Agreement with Orbis Biosciences 11
FHI 360 Enters into Co-Development Agreement with Orbis Biosciences 12
Orbis Biosciences Raises USD0.99 Million in Debt Offering 13
Orbis Biosciences Inc, Key Competitors 14
Orbis Biosciences Inc, Key Employees 15

List of Figures
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Orbis Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Orbis Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • DHL Parcel UK Ltd:企業の戦略的SWOT分析
    DHL Parcel UK Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • TransAtlantic Petroleum Ltd (TAT):企業の財務・戦略的SWOT分析
    TransAtlantic Petroleum Ltd (TAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • General Dynamics Corporation:企業の戦略・SWOT・財務情報
    General Dynamics Corporation - Strategy, SWOT and Corporate Finance Report Summary General Dynamics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Trubnaya Metallurgicheskaya Kompaniya:企業の戦略・SWOT・財務情報
    Trubnaya Metallurgicheskaya Kompaniya - Strategy, SWOT and Corporate Finance Report Summary Trubnaya Metallurgicheskaya Kompaniya - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Range Resources Corp (RRC)-石油・ガス分野:企業M&A・提携分析
    Summary Range Resources Corp (Range) is independent oil, natural gas and natural gas liquids (NGL) company that explores, develops, and acquires natural gas and oil properties in the US. It has oil and gas properties in the Appalachian basin and Northern Louisiana of the US. Range’s natural gas and …
  • Hurricane Energy plc (HUR):企業の財務・戦略的SWOT分析
    Summary Hurricane Energy Plc (Hurricane) is an oil and gas exploration and development company that discovers and develops oil from fractured basement reservoirs. The company provides exploration properties such as lancaster basement prospect, whirlwind basement discovery, lincoln basement prospect, …
  • American Axle & Manufacturing Holdings, Inc.
    American Axle & Manufacturing Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Axle & Manufacturing Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • NARI Technology Development Co Ltd (600406):企業の財務・戦略的SWOT分析
    NARI Technology Development Co Ltd (600406) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Gfk SE (GFK):企業の財務・戦略的SWOT分析
    Summary GfK SE (GfK) is a business service provider that offers market and consumer services. The company provides solutions such as online pricing intelligence, brand and customer experience, point of sales analytics, digital marketing intelligence, consumer panels, product catalogs, market opportu …
  • PTB Group Limited:企業の戦略・SWOT・財務情報
    PTB Group Limited - Strategy, SWOT and Corporate Finance Report Summary PTB Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • HCL Technologies Ltd (HCLTECH):企業の財務・戦略的SWOT分析
    HCL Technologies Ltd (HCLTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Ignyta Inc (RXDX)-製薬・医療分野:企業M&A・提携分析
    Summary Ignyta Inc (Ignyta), formerly NexDx Inc is a drug manufacturing company that discovers, develops and commercializes new drugs targeting activated genes in cancer cells for the treatment of cancer patients. The company develops products using integrated therapeutic (Rx) and companion diagnost …
  • FibroGen Inc (FGEN)-製薬・医療分野:企業M&A・提携分析
    Summary FibroGen Inc (FibroGen) is a biotechnology company that discovers, develops and commercializes new therapeutics. The company’s pipeline product portfolio includes FG-4592, an oral small molecule inhibitor of HIF prolyl hydroxylases that is used for the treatment of anemia in chronic kidney d …
  • Ego Pharmaceuticals Pty Ltd:企業の戦略的SWOT分析
    Ego Pharmaceuticals Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Lululemon Athletica, Inc. (LULU):企業の財務・戦略的SWOT分析
    Lululemon Athletica, Inc. (LULU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Biovotion AG:医療機器:M&Aディール及び事業提携情報
    Summary Biovotion AG (Biovotion) is a medical device company that offers healthcare monitoring solutions. The company offers Ecosystem, Everion and Augment app. Its Ecosystem is a wearable sensor monitor that consists of data collection, analytics, storage in the cloud and visualization tools used i …
  • Frontera Energy Corp (FEC):企業の財務・戦略的SWOT分析
    Frontera Energy Corp (FEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • World Of Medicine GmbH:企業の戦略的SWOT分析
    World Of Medicine GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Getac Technology Corporation:企業の戦略・SWOT・財務情報
    Getac Technology Corporation - Strategy, SWOT and Corporate Finance Report Summary Getac Technology Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Siem Offshore Inc (SIOFF):石油・ガス:M&Aディール及び事業提携情報
    Summary Siem Offshore Inc (Siem Offshore), a subsidiary of Siem Industries Inc is a marine service provider that owns and operates modern offshore support vessels for the offshore oil and gas industries. The company offers shipbuilding, ordering and delivery of new vessels, acquisition of modern sec …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆